Microbot Medical (MBOT) just unveiled an announcement.
Microbot Medical Inc. has announced a Phase 2 collaboration with Corewell HealthTM to push the boundaries of remote telesurgery for endovascular procedures. Their joint effort will focus on developing simulated cardiovascular interventions using the LIBERTY® Endovascular Robotic System across multiple sites. While this news is forward-looking and involves typical uncertainties, it signals a commitment to innovation in the medical field, offering a glimpse into the future of surgical technology.
Find detailed analytics on MBOT stock on TipRanks’ Stock Analysis page.
